ARWR
Arrowhead Pharmaceuticals
$86.00
▲ +1.59%
+$1.35
NYSE · Healthcare · Biotechnology
· price updated 9h ago
Arrowhead Pharmaceuticals
ARWR · NYSE · Healthcare · Biotechnology · price updated 9h ago
$86.00
▲ +1.59% · +$1.35 today
AI research · $86.00
Track ARWR for continuous AI research
price position
Where ARWR sits now
52-week range
Low$14.30
High$87.83
Today $86.00
RSI (14)
49.0Neutral
03070100
fundamentals
Business quality and valuation
Operating record
What the business has actually produced
Revenue
Capital structure
Cash versus debt
Cash & investments$147.5M
Total debt$1.4B
Net cash after debt$-1.2B
Valuation
What the market charges
Forward P/E
Price against expected earnings
No signal · Not enough data to judge
-
Price / sales
Value assigned to each sales dollar
Rich · Above 8x annual sales
19.17x
Price / FCF
Price against free cash generation
No signal · Not enough data to judge
-
EV / EBITDA
Operating value including debt
No signal · Not enough data to judge
-
Quality
How efficiently it compounds
ROIC
Return earned on invested capital
Weak · Below 8% return on capital
-81.2%
ROE
Profit generated from shareholder equity
Needs attention · Among weakest in sector
-42.4%
Debt / equity
Balance-sheet leverage
Needs attention · Among weakest in sector
2.31x
Current ratio
Short-term assets against liabilities
Strong · Comfortable short-term liquidity
6.23x
Selected financial data sourced from StockAnalysis and refreshed weekly. Figures may be delayed and are for research context, not investment advice.
peer comparison
How ARWR compares
| company | mkt cap | P/E | rev growth | score |
|---|---|---|---|---|
| $11.92B | - | +14.1% | 37 |
 | $10.69B | 18.4 | +23.5% | 78 |
 | $4.88B | 20.3 | +10.3% | 77 |
 | $31.49B | 32.9 | +15.5% | 77 |
 | $1.08T | 41.4 | +47.4% | 76 |
US stock research
About Arrowhead Pharmaceuticals (ARWR) stock
Arrowhead Pharmaceuticals tracked in the US core universe. ARWR was +1.6% in the latest available session at $86.00. Its reported market value was $11.92B with a trailing P/E of 0.0. Latest reported revenue was $622.01M, changing +14.1% year over year, with $-300.91M in net income.
Market snapshot updated Aug 3, 2026, 7:59 PM UTC.
- Latest available price
- $86.00
- Day change
- +1.6%
- Market cap
- $11.92B
- P/E (TTM)
- 0.0
- Revenue growth
- +14.1%
- Industry
- Biotechnology